GV 2021 GP, L.L.C.'s Net Worth
$240 Million
Who is GV 2021 GP, L.L.C.?
GV 2021 GP, L.L.C. has an estimated net worth of $240 Million. This is based on reported shares across multiple companies, which include Gitlab Inc., and Prime Medicine, Inc..
SEC CIK
GV 2021 GP, L.L.C.'s CIK is 0001861206
Past Insider Trading and Trends
2022 was GV 2021 GP, L.L.C.'s most active year for acquiring shares with 23 total transactions. GV 2021 GP, L.L.C.'s most active month to acquire stocks was the month of April. 2023 was GV 2021 GP, L.L.C.'s most active year for disposing of shares, totalling 55 transactions. GV 2021 GP, L.L.C.'s most active month to dispose stocks was the month of April. 2022 saw GV 2021 GP, L.L.C. paying a total of $51,182,543.56 for 14,355,167 shares, this is the most they've acquired in one year. In 2023 GV 2021 GP, L.L.C. cashed out on 2,044,380 shares for a total of $20,007,708.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gitlab Inc. (GTLB) Snapshot price: $72.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.28% | 7.29K |
$26.98 | $196,583.57 | 2.65M |
May 5
| |||
Form 4
| +36.52% | 706.29K |
$27.57 | $19,473,992.79 | 2.64M |
May 3 - May 4
| |||
Form 4
| +49.38% | 639.21K |
$29.71 | $18,988,146.10 | 1.93M |
Mar 13 - Mar 14
| |||
Form 4
| +20.67% | 221.74K |
$34.89 | $7,735,999.33 | 1.29M |
Nov 8 - Nov 9
| |||
Form 4
| +80.79% | 479.39K |
$35.65 | $17,090,059.36 | 1.07M |
Nov 4 - Nov 7
| |||
Form 4
| +2.33% | 13.53K |
$33.72 | $456,149.28 | 593.4K |
May 24
| |||
Form 4
| +4.33% | 24.04K |
$33.26 | $799,618.42 | 579.87K |
May 12
| |||
Form 4
| +148.09% | 331.78K |
$34.66 | $11,500,717.16 | 555.83K |
May 10 - May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $6.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.10% | -112.82K |
$15.02 | -$847,744.04 | 10.1M |
Jun 20 - Jun 21
| |||
Form 4
| -1.42% | -146.38K |
$14.97 | -$1,092,434.97 | 10.16M |
Jun 15 - Jun 16
| |||
Form 4
| -1.10% | -114.12K |
$15.00 | -$855,786.85 | 10.23M |
Jun 13 - Jun 14
| |||
Form 4
| -0.61% | -63.41K |
$14.73 | -$467,134.63 | 10.29M |
Jun 9 - Jun 12
| |||
Form 4
| -0.39% | -40.00K |
$16.33 | -$332,557.00 | 10.32M |
Jun 7 - Jun 8
| |||
Form 4
| -1.00% | -104.82K |
$16.86 | -$884,777.42 | 10.34M |
Jun 5 - Jun 6
| |||
Form 4
| -1.18% | -123.71K |
$14.01 | -$876,197.61 | 10.39M |
May 31 - Jun 1
| |||
Form 4
| -0.56% | -58.81K |
$13.70 | -$402,843.55 | 10.45M |
May 26 - May 30
| |||
Form 4
| -0.59% | -62.12K |
$13.52 | -$417,893.25 | 10.48M |
May 24 - May 25
| |||
Form 4
| -2.45% | -263.72K |
$14.44 | -$1,889,739.36 | 10.51M |
May 22 - May 23
| |||
Form 4
| -1.55% | -167.54K |
$13.32 | -$1,230,337.74 | 10.65M |
May 18 - May 19
| |||
Form 4
| -0.61% | -65.65K |
$12.63 | -$829,275.47 | 10.74M |
May 16 - May 17
| |||
Form 4
| -1.69% | -185.24K |
$12.74 | -$2,359,308.93 | 10.8M |
May 12 - May 15
| |||
Form 4
| -1.03% | -114.02K |
$13.82 | -$1,575,337.42 | 10.99M |
May 10 - May 11
| |||
Form 4
| -3.66% | -422.01K |
$14.09 | -$5,946,340.40 | 11.1M |
May 8 - May 9
| |||
Form 4
|
∞
| 13.28M |
$17.00 |
—
| 13.28M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||